Back to Studies

P1081 / 3 Regimens for HIV Infected Women initiating ARV regimens for PMTCT

A Randomized Trial to Evaluate the Virologic Response and Pharmacokinetics of Three Different Potent Regimens in HIV-infected Women Initiating HAART Between 28 and 36 Weeks of Pregnancy for the Prevention of Mother-to-Child Transmission

Study Status

Temporarily Closed (Paused) to Accrual and Study Agents/Products

Locality

US & Non-US

DAIDS Number

10770

IND Number

111,297, 112,049
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...